CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.250
0.00 (0.00%)
Jun 26, 2026, 3:59 PM EST
CytoDyn Employees
CytoDyn had 13 employees as of May 31, 2025. The number of employees increased by 4 or 44.44% compared to the previous year.
Employees
13
Change (1Y)
4
Growth (1Y)
44.44%
Revenue / Employee
n/a
Profits / Employee
-$3,098,154
Market Cap
338.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Northwest Biotherapeutics | 105 |
| Silence Therapeutics | 88 |
| Vaxart | 65 |
| Cell Source | 1 |
| Nuo Therapeutics | 10 |
| Vicapsys Life Sciences | 2 |
CytoDyn News
- 18 days ago - CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer's Disease - GlobeNewsWire
- 25 days ago - Natera, CytoDyn collaborate to advance ctDNA-guided development - TheFly
- 5 weeks ago - CytoDyn Transcript: 16th Annual LD Micro Invitational Conference - Transcripts
- 6 weeks ago - CytoDyn to Present at the LD Micro Invitational XVI - GlobeNewsWire
- 2 months ago - CytoDyn Transcript: Study update - Transcripts
- 2 months ago - CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer - GlobeNewsWire
- 2 months ago - CytoDyn to Host Investor Webcast - GlobeNewsWire
- 2 months ago - CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 - GlobeNewsWire